The hot cell and gene therapy market continues to make news and is featured in our top five countdown.
1. FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
2. FDA Approves Treatment for Relapsed Or Refractory Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma
3. FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
4. Catalent Adds Cryogenic Capabilities at Shiga, Japan, to Support Cell and Gene Therapy Demand
5. Cell and Gene Therapy CDMO Makes Major US Acquisition
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.